RG
EPZM
Redmile Group’s Epizyme, Inc EPZM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-454,475
| Closed | -$523K | – | 74 |
|
2022
Q1 | $523K | Hold |
454,475
| – | – | 0.02% | 70 |
|
2021
Q4 | $1.14M | Sell |
454,475
-7,004,185
| -94% | -$17.5M | 0.03% | 71 |
|
2021
Q3 | $38.2M | Sell |
7,458,660
-1,056,400
| -12% | -$5.41M | 0.67% | 43 |
|
2021
Q2 | $70.8M | Sell |
8,515,060
-309,306
| -4% | -$2.57M | 1.05% | 31 |
|
2021
Q1 | $76.9M | Sell |
8,824,366
-625,939
| -7% | -$5.45M | 1.08% | 34 |
|
2020
Q4 | $103M | Buy |
9,450,305
+1,138,672
| +14% | +$12.4M | 1.24% | 22 |
|
2020
Q3 | $99.2M | Sell |
8,311,633
-173,972
| -2% | -$2.08M | 1.82% | 12 |
|
2020
Q2 | $136M | Sell |
8,485,605
-282,870
| -3% | -$4.54M | 2.52% | 11 |
|
2020
Q1 | $136M | Buy |
8,768,475
+22,442
| +0.3% | +$348K | 3.81% | 8 |
|
2019
Q4 | $215M | Buy |
8,746,033
+109,100
| +1% | +$2.68M | 5.15% | 5 |
|
2019
Q3 | $89.1M | Sell |
8,636,933
-92,209
| -1% | -$951K | 2.98% | 10 |
|
2019
Q2 | $110M | Buy |
8,729,142
+1,035,122
| +13% | +$13M | 3.1% | 7 |
|
2019
Q1 | $95.3M | Buy |
7,694,020
+1,056,742
| +16% | +$13.1M | 2.79% | 10 |
|
2018
Q4 | $40.9M | Buy |
6,637,278
+4,389,089
| +195% | +$27M | 1.64% | 21 |
|
2018
Q3 | $23.8M | Buy |
2,248,189
+226,800
| +11% | +$2.4M | 0.73% | 46 |
|
2018
Q2 | $27.4M | Buy |
2,021,389
+9,400
| +0.5% | +$127K | 0.93% | 39 |
|
2018
Q1 | $35.7M | Buy |
2,011,989
+86,300
| +4% | +$1.53M | 1.38% | 28 |
|
2017
Q4 | $24.2M | Buy |
1,925,689
+715,689
| +59% | +$8.98M | 1.05% | 35 |
|
2017
Q3 | $23.1M | Buy |
+1,210,000
| New | +$23.1M | 1.14% | 31 |
|